Bausch Health Companies Inc. Repayments of Short-term Debt
Bausch Health Companies Inc. (BHC) reported Repayments of Short-term Debt of $0 for the 12-month period ending 2021-12-31, per its 8-K filed 2022-05-11.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfShortTermDebt · last filed 2022-05-11
- Bausch Health Companies Inc. repayments of short-term debt for the quarter ending 2021-12-31 was $0.00.
- Bausch Health Companies Inc. repayments of short-term debt for the quarter ending 2020-12-31 was $0.00.
- Bausch Health Companies Inc. repayments of short-term debt for the quarter ending 2020-09-30 was $1.00M, a 75.00% decline year-over-year.
- Bausch Health Companies Inc. repayments of short-term debt for the quarter ending 2019-12-31 was $0.00, a 100.00% decline year-over-year.
- Bausch Health Companies Inc. repayments of short-term debt for fiscal 2017 was $8.00M, a 166.67% increase from fiscal 2016.
- Bausch Health Companies Inc. repayments of short-term debt for fiscal 2016 was $3.00M.
- Bausch Health Companies Inc. repayments of short-term debt for fiscal 2014 was $28.00M, a 62.72% decline from fiscal 2013.
- Bausch Health Companies Inc. repayments of short-term debt for fiscal 2013 was $75.10M, a 141.48% increase from fiscal 2012.
| Period end | Repayments of Short-term Debt 3 month | Repayments of Short-term Debt 3 month as first filed | Repayments of Short-term Debt 6 month | Repayments of Short-term Debt 6 month as first filed | Repayments of Short-term Debt 9 month | Repayments of Short-term Debt 9 month as first filed | Repayments of Short-term Debt 12 month | Repayments of Short-term Debt 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 8-K 12 month − 10-Q 9 month · filed 2022-05-11 | $0.00 8-K · filed 2022-05-11 | ||||||
| 2021-09-30 | $0.00 10-Q · filed 2021-11-02 | |||||||
| 2020-12-31 | $0.00 derived: 8-K 12 month − 10-Q 9 month · filed 2022-05-11 | $1.00M derived: sum of 2 quarters · filed 2022-05-11 | $1.00M 8-K · filed 2022-05-11 | |||||
| 2020-09-30 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $1.00M 10-Q · filed 2021-11-02 | ||||||
| 2020-06-30 | $0.00 10-Q · filed 2020-08-06 | |||||||
| 2019-12-31 | $0.00 derived: 8-K 12 month − 10-Q 9 month · filed 2022-05-11 | $4.00M derived: sum of 2 quarters · filed 2022-05-11 | $12.00M derived: sum of 3 quarters · filed 2022-05-11 | $12.00M 8-K · filed 2022-05-11 | ||||
| 2019-09-30 | $4.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-03 | $12.00M derived: sum of 2 quarters · filed 2020-11-03 | $12.00M 10-Q · filed 2020-11-03 | $14.00M derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2019-06-30 | $8.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $8.00M 10-Q · filed 2020-08-06 | $10.00M derived: sum of 3 quarters · filed 2021-05-04 | $10.00M derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2019-03-31 | $0.00 10-Q · filed 2019-05-06 | $2.00M derived: sum of 2 quarters · filed 2021-05-04 | $2.00M derived: sum of 3 quarters · filed 2021-05-04 | $2.00M derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2018-12-31 | $2.00M derived: 8-K 12 month − 10-Q 9 month · filed 2021-05-04 | $2.00M derived: sum of 2 quarters · filed 2021-05-04 | $2.00M derived: sum of 3 quarters · filed 2021-05-04 | $3.00M 8-K · filed 2021-05-04 | ||||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $0.00 derived: sum of 2 quarters · filed 2019-11-04 | $1.00M 10-Q · filed 2019-11-04 | $1.00M derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $1.00M 10-Q · filed 2019-08-06 | $1.00M derived: sum of 3 quarters · filed 2020-02-19 | $2.00M derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2018-03-31 | $1.00M 10-Q · filed 2019-05-06 | $1.00M derived: sum of 2 quarters · filed 2020-02-19 | $2.00M derived: sum of 3 quarters · filed 2020-02-19 | $8.00M derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | $1.00M derived: sum of 2 quarters · filed 2020-02-19 | $7.00M derived: sum of 3 quarters · filed 2020-02-19 | $8.00M 10-K · filed 2020-02-19 | ||||
| 2017-09-30 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $7.00M derived: sum of 2 quarters · filed 2018-11-06 | $8.00M 10-Q · filed 2018-11-06 | $8.00M derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2017-06-30 | $6.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $7.00M 10-Q · filed 2018-08-07 | $7.00M derived: sum of 3 quarters · filed 2019-02-20 | $8.00M derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2017-03-31 | $1.00M 10-Q · filed 2018-05-08 | $1.00M derived: sum of 2 quarters · filed 2019-02-20 | $2.00M derived: sum of 3 quarters · filed 2019-02-20 | $3.00M derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | $1.00M derived: sum of 2 quarters · filed 2019-02-20 | $2.00M derived: sum of 3 quarters · filed 2019-02-20 | $3.00M 10-K · filed 2019-02-20 | ||||
| 2016-09-30 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $2.00M derived: sum of 2 quarters · filed 2017-11-07 | $3.00M 10-Q · filed 2017-11-07 | $2.80M 10-Q · filed 2016-11-09 | $3.90M derived: sum of 4 quarters · filed 2018-08-10 | |||
| 2016-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $2.00M 10-Q · filed 2017-08-08 | $1.90M 10-Q · filed 2016-08-09 | $2.90M derived: sum of 3 quarters · filed 2018-08-10 | $2.90M derived: sum of 4 quarters · filed 2018-08-10 | |||
| 2016-03-31 | $1.00M 10-Q · filed 2017-05-09 | $700.00K 10-Q · filed 2016-06-07 | $1.90M derived: sum of 2 quarters · filed 2018-08-10 | $1.90M derived: sum of 3 quarters · filed 2018-08-10 | $3.12B derived: sum of 4 quarters · filed 2018-08-10 | |||
| 2015-12-31 | $900.00K derived: 8-K 12 month − 10-Q 9 month · filed 2018-08-10 | $900.00K derived: sum of 2 quarters · filed 2018-08-10 | $3.12B derived: sum of 3 quarters · filed 2018-08-10 | $8.00M 8-K · filed 2018-08-10 | $7.90M 10-K · filed 2016-04-29 | |||
| 2015-09-30 | $0.00 10-Q · filed 2015-10-26 | $3.12B derived: sum of 2 quarters · filed 2015-10-26 | $7.10M 10-Q · filed 2016-11-09 | $3.12B 10-Q · filed 2015-10-26 | $3.15B derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2015-06-30 | $3.12B 10-Q · filed 2015-07-28 | $5.00M 10-Q · filed 2016-08-09 | $3.12B 10-Q · filed 2015-07-28 | $3.15B derived: sum of 3 quarters · filed 2017-03-01 | $3.15B derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2015-03-31 | $2.30M 10-Q · filed 2016-06-07 | $30.30M derived: sum of 2 quarters · filed 2017-03-01 | $30.30M derived: sum of 3 quarters · filed 2017-03-01 | $30.30M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2014-12-31 | $28.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $28.00M derived: sum of 2 quarters · filed 2017-03-01 | $28.00M derived: sum of 3 quarters · filed 2017-03-01 | $28.00M 10-K · filed 2017-03-01 | $28.40M 10-K · filed 2015-02-25 | |||
| 2014-09-30 | $0.00 10-Q · filed 2015-10-26 | $6.00M 10-Q · filed 2014-10-24 | $0.00 derived: sum of 2 quarters · filed 2015-10-26 | $0.00 10-Q · filed 2015-10-26 | $19.20M 10-Q · filed 2014-10-24 | $42.70M derived: sum of 4 quarters · filed 2016-04-29 | ||
| 2014-06-30 | $0.00 10-Q · filed 2015-07-28 | $8.10M 10-Q · filed 2014-08-01 | $0.00 10-Q · filed 2015-07-28 | $13.20M 10-Q · filed 2014-08-01 | $42.70M derived: sum of 3 quarters · filed 2016-04-29 | $67.90M derived: sum of 4 quarters · filed 2016-04-29 | ||
| 2014-03-31 | $5.10M 10-Q · filed 2014-05-09 | $42.70M derived: sum of 2 quarters · filed 2016-04-29 | $67.90M derived: sum of 3 quarters · filed 2016-04-29 | $78.80M derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2013-12-31 | $37.60M derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-29 | $62.80M derived: sum of 2 quarters · filed 2016-04-29 | $73.70M derived: sum of 3 quarters · filed 2016-04-29 | $75.10M 10-K · filed 2016-04-29 | $75.14M 10-K · filed 2014-02-28 | |||
| 2013-09-30 | $25.20M 10-Q · filed 2014-10-24 | $25.26M 10-Q · filed 2013-11-01 | $36.10M derived: sum of 2 quarters · filed 2014-10-24 | $37.50M 10-Q · filed 2014-10-24 | $37.53M 10-Q · filed 2013-11-01 | $42.20M derived: sum of 4 quarters · filed 2015-02-25 | ||
| 2013-06-30 | $10.90M 10-Q · filed 2014-08-01 | $10.86M 10-Q · filed 2013-08-07 | $12.30M 10-Q · filed 2014-08-01 | $12.27M 10-Q · filed 2013-08-07 | $17.00M derived: sum of 3 quarters · filed 2015-02-25 | $21.82M derived: sum of 4 quarters · filed 2015-02-25 | ||
| 2013-03-31 | $1.40M 10-Q · filed 2014-05-09 | $1.42M 10-Q · filed 2013-05-03 | $6.10M derived: sum of 2 quarters · filed 2015-02-25 | $10.92M derived: sum of 3 quarters · filed 2015-02-25 | $32.50M derived: sum of 4 quarters · filed 2015-02-25 | |||
| 2012-12-31 | $4.70M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $9.52M derived: sum of 2 quarters · filed 2015-02-25 | $31.10M derived: sum of 3 quarters · filed 2015-02-25 | $31.10M 10-K · filed 2015-02-25 | $31.07M 10-K · filed 2013-02-28 | |||
| 2012-09-30 | $4.82M 10-Q · filed 2013-11-01 | $26.40M derived: sum of 2 quarters · filed 2013-11-01 | $26.40M 10-Q · filed 2013-11-01 | |||||
| 2012-06-30 | $21.58M 10-Q · filed 2013-08-07 | $21.58M 10-Q · filed 2013-08-07 | ||||||
| 2011-12-31 | $0.00 10-K · filed 2014-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |